Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation

BMC Cardiovascular Disorders

Volumn 13, Issue , 2013, Pages

  Karagiannis, George S ^a,b   Weile, Jochen ^a   Bader, Gary D ^a   Minta, Joe ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 3; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN BINDING PROTEIN 1; INHIBITOR OF DIFFERENTIATION 2; INTERLEUKIN 2; LIPOPROTEIN RECEPTOR; MICRORNA; SCATTER FACTOR; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ATHEROSCLEROSIS; CELL DEDIFFERENTIATION; CELLS, CULTURED; CORONARY VESSELS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENOTYPE; HUMANS; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; SYSTEMS BIOLOGY; TIME FACTORS;

EID: 84872175226     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-13-4     Document Type: Article

References (113)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340(2):115-126. 10.1056/NEJM199901143400207, 9887164.
2. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105(9):1135-1143. 10.1161/hc0902.104353, 11877368.
3. Lusis AJ. Atherosclerosis. Nature 2000, 407(6801):233-241. 10.1038/35025203, 2826222, 11001066.
4. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28(5):812-819. 10.1161/ATVBAHA.107.159327, 2734458, 18276911.
5. Tracy RE, Newman WP, Wattigney WA, Berenson GS. Risk factors and atherosclerosis in youth autopsy findings of the Bogalusa Heart Study. Am J Med Sci 1995, 310(Suppl 1):S37-S41.
6. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998, 338(23):1650-1656. 10.1056/NEJM199806043382302, 9614255.
7. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995, 75(3):487-517.
8. Schwartz SM. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 1997, 100(11 Suppl):S87-S89.
9. Gittenberger-de Groot AC, DeRuiter MC, Bergwerff M, Poelmann RE. Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol 1999, 19(7):1589-1594. 10.1161/01.ATV.19.7.1589, 10397674.
10. Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1977, 46:897-930. 10.1146/annurev.bi.46.070177.004341, 197883.
11. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 2004, 45(6):993-1007. 10.1194/jlr.R400001-JLR200, 15060092.
12. Harkewicz R, Hartvigsen K, Almazan F, Dennis EA, Witztum JL, Miller YI. Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein. J Biol Chem 2008, 283(16):10241-10251. 10.1074/jbc.M709006200, 2447632,2447632, 18263582.
13. Cathcart MK, Folcik VA. Lipoxygenases and atherosclerosis: protection versus pathogenesis. Free Radic Biol Med 2000, 28(12):1726-1734. 10.1016/S0891-5849(00)00230-6, 10946214.
14. Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003, 10(2):63-71. 10.5551/jat.10.63, 12740479.
15. Virella G, Lopes-Virella MF. Atherogenesis and the humoral immune response to modified lipoproteins. Atherosclerosis 2008, 200(2):239-246. 10.1016/j.atherosclerosis.2008.03.025, 2605965, 18513726.
16. Loppnow H, Werdan K, Buerke M. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Innate Immun 2008, 14(2):63-87. 10.1177/1753425908091246, 18713724.
17. Louis H, Lacolley P, Kakou A, Cattan V, Daret D, Safar M, Bonnet J, Daniel Lamaziere JM. Early activation of internal medial smooth muscle cells in the rabbit aorta after mechanical injury: relationship with intimal thickening and pharmacological applications. Clin Exp Pharmacol Physiol 2006, 33(1-2):131-138. 10.1111/j.1440-1681.2006.04339.x, 16445712.
18. Raines EW, Ferri N. Thematic review series: The immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res 2005, 46(6):1081-1092. 10.1194/jlr.R500004-JLR200, 15834121.
19. Massaeli H, Hurtado C, Austria JA, Pierce GN. Oxidized low-density lipoprotein induces cytoskeletal disorganization in smooth muscle cells. Am J Physiol 1999, 277(5 Pt 2):H2017-H2025.
20. Robenek H, Severs NJ. Lipoprotein receptors on macrophages and smooth muscle cells. Curr Top Pathol 1993, 87:73-123. 10.1007/978-3-642-76849-1_4, 8125027.
21. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 2001, 81(3):999-1030.
22. Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao T, Miyazaki H, Iwao H. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol 2003, 23(5):795-801. 10.1161/01.ATV.0000066132.32063.F2, 12637337.
23. Lien SC, Usami S, Chien S, Chiu JJ. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells. Cell Signal 2006, 18(8):1270-1278. 10.1016/j.cellsig.2005.10.013, 16310342.
24. Tabibiazar R, Wagner RA, Ashley EA, King JY, Ferrara R, Spin JM, Sanan DA, Narasimhan B, Tibshirani R, Tsao PS, et al. Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease. Physiol Genomics 2005, 22(2):213-226. 10.1152/physiolgenomics.00001.2005, 15870398.
25. King JY, Ferrara R, Tabibiazar R, Spin JM, Chen MM, Kuchinsky A, Vailaya A, Kincaid R, Tsalenko A, Deng DX, et al. Pathway analysis of coronary atherosclerosis. Physiol Genomics 2005, 23(1):103-118. 10.1152/physiolgenomics.00101.2005, 15942018.
26. Ashley EA, Ferrara R, King JY, Vailaya A, Kuchinsky A, He X, Byers B, Gerckens U, Oblin S, Tsalenko A, et al. Network analysis of human in-stent restenosis. Circulation 2006, 114(24):2644-2654. 10.1161/CIRCULATIONAHA.106.637025, 17145989.
27. Skogsberg J, Lundstrom J, Kovacs A, Nilsson R, Noori P, Maleki S, Kohler M, Hamsten A, Tegner J, Bjorkegren J. Transcriptional profiling uncovers a network of cholesterol- responsive atherosclerosis target genes. PLoS Genet 2008, 4(3):e1000036. 10.1371/journal.pgen.1000036, 2265530, 18369455.
28. Cagnin S, Biscuola M, Patuzzo C, Trabetti E, Pasquali A, Laveder P, Faggian G, Iafrancesco M, Mazzucco A, Pignatti PF, et al. Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries. BMC Genomics 2009, 10:13. 10.1186/1471-2164-10-13, 2654039, 19134193.
29. Diez M, Musri MM, Ferrer E, Barbera JA, Peinado VI. Endothelial progenitor cells undergo an endothelial-to-mesenchymal transition-like process mediated by TGFbetaRI. Cardiovasc Res 2011, 88(3):502-511.
30. Wheelock CE, Wheelock AM, Kawashima S, Diez D, Kanehisa M, van Erk M, Kleemann R, Haeggstrom JZ, Goto S. Systems biology approaches and pathway tools for investigating cardiovascular disease. Mol Biosyst 2009, 5(6):588-602. 10.1039/b902356a, 19462016.
31. Gargalovic PS, Imura M, Zhang B, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Patel S, et al. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci USA 2006, 103(34):12741-12746. 10.1073/pnas.0605457103, 1568918, 16912112.
32. Minta JO, Yun JJ, Kabiawu O, Jones J. mRNA differential display identification of vascular smooth muscle early response genes regulated by PDGF. Mol Cell Biochem 2006, 281(1-2):63-75.
33. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102(43):15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
34. Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 2011, 5(11):e13984.
35. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics (Oxford, England) 2004, 20(3):307-315.
36. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (Oxford, England) 2003, 4(2):249-264.
37. Isserlin R, Merico D, Alikhani-Koupaei R, Gramolini A, Bader GD, Emili A. Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps. Proteomics 2011, 10(6):1316-1327.
38. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25(1):25-29. 10.1038/75556, 3037419, 10802651.
39. Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, Karp PD. Computational prediction of human metabolic pathways from the complete human genome. Genome Biol 2005, 6(1):R2. 549063, 15642094.
40. Kanehisa M, Goto S, Kawashima S, Nakaya A. The KEGG databases at GenomeNet. Nucleic Acids Res 2002, 30(1):42-46. 10.1093/nar/30.1.42, 99091, 11752249.
41. Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH. PID: the Pathway Interaction Database. Nucleic Acids Res 2009, 37(Database issue):D674-D679. 2686461, 18832364.
42. Kandasamy K, Mohan SS, Raju R, Keerthikumar S, Kumar GS, Venugopal AK, Telikicherla D, Navarro JD, Mathivanan S, Pecquet C, et al. NetPath: a public resource of curated signal transduction pathways. Genome Biol 2011, 11(1):R3-R37.
43. Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, De Bono B, Garapati P, Hemish J, Hermjakob H, Jassal B, et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 2009, 37(Database issue):D619-D622. 2686536, 18981052.
44. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38(Web Server issue):W214-W220.
45. Prassas I, Karagiannis GS, Batruch I, Dimitromanolakis A, Datti A, Diamandis EP. Digitoxin- Induced Cytotoxicity in Cancer Cells Is Mediated through Distinct Kinase and Interferon Signaling Networks. Mol Cancer Ther 2011, 10(11):2083-2093. 10.1158/1535-7163.MCT-11-0421, 21859838.
46. Sever N, Yang T, Brown MS, Goldstein JL, DeBose-Boyd RA. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell 2003, 11(1):25-33. 10.1016/S1097-2765(02)00822-5, 12535518.
47. Brown AJ, Sun L, Feramisco JD, Brown MS, Goldstein JL. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell 2002, 10(2):237-245. 10.1016/S1097-2765(02)00591-9, 12191470.
48. Yabe D, Brown MS, Goldstein JL. Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc Natl Acad Sci USA 2002, 99(20):12753-12758. 10.1073/pnas.162488899, 130532, 12242332.
49. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab 2008, 8(6):512-521. 10.1016/j.cmet.2008.10.008, 2652870, 19041766.
50. Nagao S, Murao K, Imachi H, Cao WM, Yu X, Li J, Matsumoto K, Nishiuchi T, Ahmed RA, Wong NC, et al. Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells. FEBS Lett 2006, 580(18):4371-4376. 10.1016/j.febslet.2006.07.001, 16854413.
51. Wang N, Silver DL, Thiele C, Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem 2001, 276(26):23742-23747. 10.1074/jbc.M102348200, 11309399.
52. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 2004, 101(26):9774-9779. 10.1073/pnas.0403506101, 470750, 15210959.
53. Kennedy MA, Barrera GC, Nakamura K, Baldan A, Tarr P, Fishbein MC, Frank J, Francone OL, Edwards PA. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 2005, 1(2):121-131. 10.1016/j.cmet.2005.01.002, 16054053.
54. Ogura M, Ayaori M, Terao Y, Hisada T, Iizuka M, Takiguchi S, Uto-Kondo H, Yakushiji E, Nakaya K, Sasaki M, et al. Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo. Arterioscler Thromb Vasc Biol 31(9):1980-1987.
55. Gelissen IC, Harris M, Rye KA, Quinn C, Brown AJ, Kockx M, Cartland S, Packianathan M, Kritharides L, Jessup W. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 2006, 26(3):534-540.
56. Fukao T, Yamaguchi S, Orii T, Schutgens RB, Osumi T, Hashimoto T. Identification of three mutant alleles of the gene for mitochondrial acetoacetyl-coenzyme A thiolase. A complete analysis of two generations of a family with 3-ketothiolase deficiency. J Clin Invest 1992, 89(2):474-479. 10.1172/JCI115608, 442875, 1346617.
57. Caldas H, Herman GE. NSDHL, an enzyme involved in cholesterol biosynthesis, traffics through the Golgi and accumulates on ER membranes and on the surface of lipid droplets. Hum Mol Genet 2003, 12(22):2981-2991. 10.1093/hmg/ddg321, 14506130.
58. Garuti R, Jones C, Li WP, Michaely P, Herz J, Gerard RD, Cohen JC, Hobbs HH. The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits. J Biol Chem 2005, 280(49):40996-41004. 10.1074/jbc.M509394200, 16179341.
59. Claudel T, Leibowitz MD, Fievet C, Tailleux A, Wagner B, Repa JJ, Torpier G, Lobaccaro JM, Paterniti JR, Mangelsdorf DJ, et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci USA 2001, 98(5):2610-2615. 10.1073/pnas.041609298, 30186, 11226287.
60. Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science (New York, NY 2008, 322(5908):1702-1705.
61. Monajemi H, Fontijn RD, Pannekoek H, Horrevoets AJ. The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics 2002, 79(4):539-546. 10.1006/geno.2002.6729, 11944986.
62. Leopold JA, Walker J, Scribner AW, Voetsch B, Zhang YY, Loscalzo AJ, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor- mediated angiogenesis. J Biol Chem 2003, 278(34):32100-32106. 10.1074/jbc.M301293200, 12777375.
63. Sasaguri T, Arima N, Tanimoto A, Shimajiri S, Hamada T, Sasaguri Y. A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells. Atherosclerosis 1998, 138(2):247-253. 10.1016/S0021-9150(97)00296-7, 9690907.
64. Chugh A, Ray A, Gupta JB. Squalene epoxidase as hypocholesterolemic drug target revisited. Prog Lipid Res 2003, 42(1):37-50. 10.1016/S0163-7827(02)00029-2, 12467639.
65. Miller YI, Choi SH, Fang L, Harkewicz R. Toll-like receptor-4 and lipoprotein accumulation in macrophages. Trends Cardiovasc Med 2009, 19(7):227-232. 10.1016/j.tcm.2010.02.001, 2854673, 20382346.
66. Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S, Witztum JL. Toll-like receptor 4- dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005, 25(6):1213-1219. 10.1161/01.ATV.0000159891.73193.31, 15718493.
67. Maziere C, Auclair M, Djavaheri-Mergny M, Packer L, Maziere JC. Oxidized low density lipoprotein induces activation of the transcription factor NF kappa B in fibroblasts, endothelial and smooth muscle cells. Biochem Mol Biol Int 1996, 39(6):1201-1207.
68. Maziere C, Alimardani G, Dantin F, Dubois F, Conte MA, Maziere JC. Oxidized LDL activates STAT1 and STAT3 transcription factors: possible involvement of reactive oxygen species. FEBS Lett 1999, 448(1):49-52. 10.1016/S0014-5793(99)00324-5, 10217408.
69. Maziere C, Conte MA, Maziere JC. Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radic Biol Med 2001, 31(11):1334-1340. 10.1016/S0891-5849(01)00649-9, 11728804.
70. Chai YC, Howe PH, DiCorleto PE, Chisolm GM. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem 1996, 271(30):17791-17797. 10.1074/jbc.271.30.17791, 8663300.
71. Ananyeva NM, Tjurmin AV, Berliner JA, Chisolm GM, Liau G, Winkles JA, Haudenschild CC. Oxidized LDL mediates the release of fibroblast growth factor-1. Arterioscler Thromb Vasc Biol 1997, 17(3):445-453. 10.1161/01.ATV.17.3.445, 9102162.
72. Auge N, Garcia V, Maupas-Schwalm F, Levade T, Salvayre R, Negre-Salvayre A. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscler Thromb Vasc Biol 2002, 22(12):1990-1995. 10.1161/01.ATV.0000043453.21629.3B, 12482824.
73. Duan C, Bauchat JR, Hsieh T. Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration. Circ Res 2000, 86(1):15-23. 10.1161/01.RES.86.1.15, 10625300.
74. Adam PJ, Clesham GJ, Flynn PD, Weissberg PL. Identification and characterisation of transforming growth factor beta-regulated vascular smooth muscle cell genes. Cytokine 2000, 12(4):348-354. 10.1006/cyto.1999.0559, 10805215.
75. Yang CM, Chien CS, Hsiao LD, Pan SL, Wang CC, Chiu CT, Lin CC. Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway. Br J Pharmacol 2001, 132(7):1531-1541. 10.1038/sj.bjp.0703976, 1572708, 11264247.
76. Escargueil-Blanc I, Salvayre R, Vacaresse N, Jurgens G, Darblade B, Arnal JF, Parthasarathy S, Negre-Salvayre A. Mildly oxidized LDL induces activation of platelet-derived growth factor beta-receptor pathway. Circulation 2001, 104(15):1814-1821. 10.1161/hc4001.097179, 11591620.
77. Gerthoffer WT. Mechanisms of vascular smooth muscle cell migration. Circ Res 2007, 100(5):607-621. 10.1161/01.RES.0000258492.96097.47, 17363707.
78. Sanada F, Taniyama Y, Iekushi K, Azuma J, Okayama K, Kusunoki H, Koibuchi N, Doi T, Aizawa Y, Morishita R. Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells. Circ Res 2009, 105(7):667-675. 613 p following 675, 10.1161/CIRCRESAHA.109.202713, 19713535.
79. Geng Y, Hansson GK, Holme E. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992, 71(5):1268-1276. 10.1161/01.RES.71.5.1268, 1394884.
80. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990, 65(5):297-302. 10.1016/0002-9149(90)90291-8, 2405620.
81. Vickers KC, Remaley AT. MicroRNAs in atherosclerosis and lipoprotein metabolism. Curr Opin Endocrinol Diabetes Obes 17(2):150-155.
82. Schroen B, Heymans S. Small but smart - microRNAs in the center of inflammatory processes during cardiovascular diseases, the metabolic syndrome and aging. Cardiovasc Res 2011,
83. Goetze S, Xi XP, Kawano Y, Kawano H, Fleck E, Hsueh WA, Law RE. TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension 1999, 33(1 Pt 2):183-189.
84. Ortiz-Munoz G, Martin-Ventura JL, Hernandez-Vargas P, Mallavia B, Lopez-Parra V, Lopez-Franco O, Munoz-Garcia B, Fernandez-Vizarra P, Ortega L, Egido J, et al. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler Thromb Vasc Biol 2009, 29(4):525-531. 10.1161/ATVBAHA.108.173781, 19164812.
85. Hirai H, Kanaya R, Maeda M, Qungfang D, Ina K, Hayashi T. The role of insulin growth factor on atherosclerosis and endothelial function: the effect on hyperlipidemia and aging. Life Sci 2011, 88(9-10):425-431.
86. Young HA, Bream JH. IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications. Curr Top Microbiol Immunol 2007, 316:97-117. 10.1007/978-3-540-71329-6_6, 17969445.
87. Horwitz AR, Parsons JT. Cell migration-movin' on. Science (New York, NY 1999, 286(5442):1102-1103.
88. Smilenov LB, Mikhailov A, Pelham RJ, Marcantonio EE, Gundersen GG. Focal adhesion motility revealed in stationary fibroblasts. Science (New York, NY 1999, 286(5442):1172-1174.
89. Willis AI, Pierre-Paul D, Sumpio BE, Gahtan V. Vascular smooth muscle cell migration: current research and clinical implications. Vasc Endovascular Surg 2004, 38(1):11-23. 10.1177/153857440403800102, 14760473.
90. Hiroki J, Shimokawa H, Higashi M, Morikawa K, Kandabashi T, Kawamura N, Kubota T, Ichiki T, Amano M, Kaibuchi K, et al. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. J Mol Cell Cardiol 2004, 37(2):537-546. 10.1016/j.yjmcc.2004.05.008, 15276023.
91. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 2007, 39(2):86-93.
92. Aidoudi S, Bikfalvi A. Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis. Thromb Haemost 2011, 104(5):941-948.
93. Wang Z, Newman WH. Smooth muscle cell migration stimulated by interleukin 6 is associated with cytoskeletal reorganization. J Surg Res 2003, 111(2):261-266. 10.1016/S0022-4804(03)00087-8, 12850472.
94. Lim CS, Shalhoub J, Gohel MS, Shepherd AC, Davies AH. Matrix metalloproteinases in vascular disease-a potential therapeutic target?. Curr Vasc Pharmacol 2011, 8(1):75-85.
95. Pace U, Lancet D. Olfactory GTP-binding protein: signal-transducing polypeptide of vertebrate chemosensory neurons. Proc Natl Acad Sci USA 1986, 83(13):4947-4951. 10.1073/pnas.83.13.4947, 323861, 3088569.
96. Spehr M, Munger SD. Olfactory receptors: G protein-coupled receptors and beyond. J Neurochem 2009, 109(6):1570-1583. 10.1111/j.1471-4159.2009.06085.x, 19383089.
97. Uglow EB, Slater S, Sala-Newby GB, Aguilera-Garcia CM, Angelini GD, Newby AC, George SJ. Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res 2003, 92(12):1314-1321. 10.1161/01.RES.0000079027.44309.53, 12775583.
98. Dwivedi A, Slater SC, George SJ. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation. Cardiovasc Res 2009, 81(1):178-186. 10.1093/cvr/cvn278, 18852254.
99. George SJ, Beeching CA. Cadherin:catenin complex: a novel regulator of vascular smooth muscle cell behaviour. Atherosclerosis 2006, 188(1):1-11. 10.1016/j.atherosclerosis.2005.12.017, 16438974.
100. George SJ, Dwivedi A. MMPs, cadherins, and cell proliferation. Trends Cardiovasc Med 2004, 14(3):100-105. 10.1016/j.tcm.2003.12.008, 15121157.
101. Hulpiau P, van Roy F. Molecular evolution of the cadherin superfamily. Int J Biochem Cell Biol 2009, 41(2):349-369. 10.1016/j.biocel.2008.09.027, 18848899.
102. Wells A, Chao YL, Grahovac J, Wu Q, Lauffenburger DA. Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Front Biosci 2011, 16:815-837. 10.2741/3722, 21196205.
103. Walker MM, Ellis SM, Auza MJ, Patel A, Clark P. The intercellular adhesion molecule, cadherin-10, is a marker for human prostate luminal epithelial cells that is not expressed in prostate cancer. Mod Pathol 2008, 21(2):85-95.
104. Liu Q, Chen Y, Pan JJ, Murakami T. Expression of protocadherin-9 and protocadherin-17 in the nervous system of the embryonic zebrafish. Gene Expr Patterns 2009, 9(7):490-496. 10.1016/j.gep.2009.07.006, 2748168, 19616130.
105. Indig FE, Diaz-Gonzalez F, Ginsberg MH. Analysis of the tetraspanin CD9-integrin alphaIIbbeta3 (GPIIb-IIIa) complex in platelet membranes and transfected cells. Biochem J 1997, 327(Pt 1):291-298. 1218793, 9355765.
106. Takeda Y, Li Q, Kazarov AR, Epardaud M, Elpek K, Turley SJ, Hemler ME. Diminished metastasis in tetraspanin CD151-knockout mice. Blood 2011, 118(2):464-472. 10.1182/blood-2010-08-302240, 3138696, 21536858.
107. Hidalgo-Carcedo C, Hooper S, Chaudhry SI, Williamson P, Harrington K, Leitinger B, Sahai E. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat Cell Biol 2011, 13(1):49-58. 10.1038/ncb2133, 3018349, 21170030.
108. Zhivotovsky B, Orrenius S. Cell cycle and cell death in disease: past, present and future. J Intern Med 2011, 268(5):395-409.
109. Sampson EM, Haque ZK, Ku MC, Tevosian SG, Albanese C, Pestell RG, Paulson KE, Yee AS. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO J 2001, 20(16):4500-4511. 10.1093/emboj/20.16.4500, 125566, 11500377.
110. Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 1994, 269(3):2139-2145.
111. Zhu X, Lin Y, Bacanamwo M, Chang L, Chai R, Massud I, Zhang J, Garcia-Barrio MT, Thompson WE, Chen YE. Interleukin-1 beta-induced Id2 gene expression is mediated by Egr-1 in vascular smooth muscle cells. Cardiovasc Res 2007, 76(1):141-148. 10.1016/j.cardiores.2007.06.015, 2094110, 17631285.
112. Damiani E, Sugiyama T, Shimamura K, Greci L, Matsuda Y. Altered expression of alpha-actin, smooth muscle myosin heavy chain-1 and calponin in cultured smooth muscle cells by oxidized low density lipoproteins. FEBS Lett 1998, 425(1):123-125. 10.1016/S0014-5793(98)00212-9, 9541019.
113. Weissberg PL, Cary NR, Shanahan CM. Gene expression and vascular smooth muscle cell phenotype. Blood Press 1995, 2:68-73.